Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

20.14
Delayed Data
As of 4:01pm ET
 -0.13 / -0.64%
Today’s Change
18.55
Today|||52-Week Range
263.81
-80.19%
Year-to-Date
How Will Pershing Fare in June? Look at Valeant
Jun 29 / TheStreet.com - Paid Partner Content
We Like Valeant Pharmaceuticals for a Trade (Video)
Jun 24 / Investing Channel - Paid Partner Content
Valeant Is Cash-Poor, and Even Bausch & Lomb Division May Not Save It
Jun 29 / TheStreet.com - Paid Partner Content
Steve Mandel Exits Position in Williams Companies in 1st Quarter
Jun 24 / GuruFocus News - Paid Partner Content
Valeant Needs Cash and 'Crown Jewel' Bausch & Lomb May Be Losing Value
Jun 29 / TheStreet.com - Paid Partner Content
This Merger Could Mean Returns Of Up To 40%
Jun 24 / StreetAuthority - Paid Partner Content
Wells Fargo Says Even Bausch & Lomb Sale May Not Solve Valeant Problems
Jun 29 / TheStreet.com - Paid Partner Content
Better Buy: Valeant Pharmaceuticals International, Inc. vs. Allergan
Jun 23 / MotleyFool.com - Paid Partner Content
Valeant Pharmaceuticals (VRX) Stock Slumps, BMO Initiates Coverage
Jun 29 / TheStreet.com - Paid Partner Content
Forget a 'Flash Crash'; How About a 'Flash Squeeze' Instead?
Jun 23 / TheStreet.com - Paid Partner Content
The 2 Big Reasons Valeant Pharmaceuticals Intl. Inc., Shares Are Down 80% in 2016
Jun 29 / MotleyFool.com - Paid Partner Content
Valeant Pharmaceuticals (VRX) Stock Rating Downgraded at JPMorgan
Jun 23 / TheStreet.com - Paid Partner Content
Valeant Pharmaceuticals International (VRX) Leading In Pre-Market Activity
Jun 29 / TheStreet.com - Paid Partner Content
3 Stocks That Have Been Cut in Half This Year
Jun 23 / MotleyFool.com - Paid Partner Content
Forget Valeant, Invest in These Attractive Drug Stocks Instead
Jun 28 / Zacks.com - Paid Partner Content
How Much Is Valeant Pharmaceuticals Really Worth?
Jun 17 / MotleyFool.com - Paid Partner Content
14 Toxic Must-Sell Investments That Will Be Hit Hardest by Brexit
Jun 28 / TheStreet.com - Paid Partner Content
9 Easy Ways to Lose Money in the Stock Market
Jun 17 / MotleyFool.com - Paid Partner Content
3 Stocks on my Brexit Shopping List
Jun 28 / TheStreet.com - Paid Partner Content
Should You Get Rid of Valeant Pharmaceuticals (VRX) Now?
Jun 16 / Zacks.com - Paid Partner Content
Trade-Ideas: Valeant Pharmaceuticals International (VRX) Is Today's "Dead Cat Bounce"...
Jun 28 / TheStreet.com - Paid Partner Content
Stocks: 4 things to know before the open
Jun 07 / CNNMoney.com
Valeant (VRX) Stock Tumbles, Analysts' Concerns Mount After Brexit
Jun 27 / TheStreet.com - Paid Partner Content
Valeant CEO gets $9 million golden parachute
Jun 01 / CNNMoney.com